SCPEC
Հայ Eng Рус
Home |Feedback|FAQ|Site Map
 Search
SCPEC RA was established in 2001

6-th UN conference on Competition Policy

Armenia. Peer Review

ARMENIA IS A MEMBER OF ICAP

ICAP XXXXIV ORDINARY SESSION, 13-15 APRIL 2016,YEREVAN

ARMENIA IS A MEMBER OF ICN

ICN 16th Annual Conference

Get Adobe Reader
 
Press Releases
«Vaga Pharm» company submitted a complaint to the Commission against «Natali Pharm» and «Alpha Pharm» companies

«Vaga Pharm» company submitted a complaint to the Commission against «Natali Pharm» and «Alpha Pharm» pharmaceutical companies. «Vaga Pharm» informed that it acquires some drugs for its wholesale and retail sale from above mentioned two companies. According to the complaint other economic entities operating in the sphere are provided discounts in case of smaller acquisitions, however in the case of incomparably greater number of orders by them the equivalent discounts are not applied. «Vaga Pharm» notes that it cannot compete on equal terms, since other companies can implement a more flexible pricing policy due to the large discounts offered to them. The complainant also notes that he repeatedly asked suppliers to apply discounts to them on an equal basis with others, however, their request was denied with the shady arguments.

In the scope of administrative proceeding initiated on the basis of above mentioned complaint the Commission organized discussion with the participation of representatives of «Vaga Pharm», «Natali Pharm» and «Alpha Pharm» companies. In response to «Vaga Pharm» the above mentioned companies expressed their position on the issue to the Commission, in particular noting that their discount policy is not determined only by the amount of pharmaceutical drugs purchased by the customer, but the other criteria also apply. Actually without denying the fact of the implementation of discriminatory policy in relation to economic entities engaged in the sale of pharmaceutical drugs, they informed the Commission that applied discounts are based on long-term agreements, the predictability of the economic entity, the acquisition of all types of pharmaceutical drugs offered, proper representation in pharmacy chains and a number of other criteria. In addition, they also noted that discounts are provided to all acquirers, and additional discounts are provided not to all.

In the scope of administrative proceeding RA Competition authority will carry out comprehensive study and l publish its decision on the issue.

 

14/12/2018
 2018
 December
 
 
This website was developed with the assistance of the United States Agency
for International Development (USAID).
The views expressed do not necessarily reflect those of the United States Agency for International Development or the United States Government.